Sudeep Pharma Ltd. (SUDEEPPHRM): Sudeep Pharma Share Price rises 5% to Rs 1,161.50; market cap at Rs 12,515.84 crore
- September 18, 2026
- Posted by: Harsh Piplani
- Category: News
Sudeep Pharma Share Price moved higher today as Sudeep Pharma Ltd. ended at Rs 1,161.50, up 5.00% from the previous close of Rs 1,106.20. The stock added Rs 55.30 during the session, with the day open at Rs 1,109.80 and the day high matching the day close at Rs 1,161.50. Market capitalisation stood at Rs 12,515.84 crore, placing the move in a clear market-cap context for investors following Sudeep Pharma Share Price Today and Sudeep Pharma Stock News.
The supplied data confirms the price event but does not establish a company-specific catalyst. What it does show is a same-day share price rise alongside turnover of Rs 1.61 crore, which makes the session relevant for readers tracking Sudeep Pharma Share Price, Sudeep Pharma Share Price Update and broader Stocks in News within the Indian Stock Market. Univest is following the move through a mix of price action, valuation, sector context and financial ratios so the event can be read in a structured way rather than as a standalone headline.
For investors scanning Sudeep Pharma Share Price Today, the immediate questions are straightforward: what changed in the session, how the valuation compares with the Pharmaceuticals & Drugs benchmark, and whether the company’s reported profitability metrics justify the current market setup. Univest addresses those points below using only the supplied figures.
Sudeep Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,161.5 |
| Previous Close | Rs 1,106.2 |
| Today's Move | Rs 55.3 (+5%) |
| Open | Rs 1,109.8 |
| High | Rs 1,161.5 |
| Low | Rs 1,109.8 |
| Turnover | Rs 1.61 crore |
| Market Capitalisation | Rs 12,515.84 crore |
| Market Cap Category | Mid Cap |
Sudeep Pharma Ltd. (SUDEEPPHRM) rose to Rs 1,161.5 from the previous close of Rs 1,106.2, a move of Rs 55.3 or 5%. The stock opened at Rs 1,109.8, reached a high of Rs 1,161.5, recorded a low of Rs 1,109.8.
Sudeep Pharma Share Price Today was higher by 5.00%, or Rs 55.30, from Rs 1,106.20 to Rs 1,161.50. The stock opened at Rs 1,109.80, stayed within that day’s range, and closed at the session high of Rs 1,161.50. Turnover was Rs 1.61 crore. The data confirms a same-day price rise, while the reason for the move is not established in the supplied record.
On a simple day-to-day basis, that means Sudeep Pharma Share Price finished above both its opening level and previous close, making it one of the notable Stock Market Today movers within the healthcare space. For readers of Sudeep Pharma Stock News, the verified facts are limited to the price change, the session range and traded value, not a disclosed trigger.
Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 12,515.84 crore |
| P/E Ratio | 68.41x |
| P/B Ratio | 13.52x |
| ROE | 25.37% |
| ROCE | 28.5% |
| EPS | Rs 16.17 |
| Book Value Per Share | Rs 81.8 |
| Dividend Yield | 0.14% |
Sudeep Pharma Ltd. (SUDEEPPHRM) fundamental metrics show P/E 68.41x, P/B 13.52x, ROE 25.37%, ROCE 28.5%. These figures provide context only and are not a buy or sell signal.
Sudeep Pharma Ltd. has a market capitalisation of Rs 12515.84 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 68.41x, P/B at 13.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 25.37% and ROCE of 28.5%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 16.17, book value per share of Rs 81.8, dividend yield of 0.14%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.69x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 68.41x |
| Benchmark Median P/E | 32.69x |
| Benchmark Average P/E | 44.72x |
| Benchmark P/E Range | 3.44x to 417.17x |
| Company P/B Ratio | 13.52x |
| Benchmark Median P/B | 3.1x |
| Company ROE | 25.37% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 28.5% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 12,515.84 crore |
| Benchmark Median Market Cap | Rs 741.38 crore |
Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 68.41x, which is above the benchmark median of 32.69x, a difference of +109.27%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of 25.37%, which is above the benchmark median of 11.78%, a difference of +115.37%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of 28.5%, which is above the benchmark median of 13.65%, a difference of +108.79%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,44,716.74 | 37.01 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,223.13 | 84.83 | 14.05 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,83,453.32 | 85.3 | 20.73 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,10,224.17 | 25.14 | 4.21 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,09,848.55 | 32.89 | 3.15 | 11.83 | 16 |
Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 68.41x compared with the displayed peer median of 37.01x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 25.37% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 28.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 12,515.84 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Sudeep Pharma
- Sudeep Pharma Share Price rose 5.00% today to Rs 1,161.50, after closing above the previous close of Rs 1,106.20.
- The stock’s market capitalisation stood at Rs 12,515.84 crore, which places the move in a clearly defined size context.
- P/E is 68.41 and P/B is 13.52, both above the same-industry benchmark median and average.
- ROE of 25.37% and ROCE of 28.50% are both higher than the benchmark median and average for the same industry set.
- Turnover was Rs 1.61 crore, and the session closed at the day high of Rs 1,161.50.
About Sudeep Pharma
Sudeep Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied classification, it is part of a sector where listed companies are typically assessed on profitability, valuation and product-led business strength. The data provided here does not include a segment breakdown, product list or revenue mix, so the company should be understood through the verified market figures available in this note.
From a market perspective, Sudeep Pharma Share Price is being viewed through its listed identity on NSE and BSE, its earnings ratios and its position versus other pharmaceutical companies. That makes Sudeep Pharma Stock Analysis relevant not only for daily Share Market Today watchers, but also for readers comparing valuation, profitability and market capitalisation across healthcare names. Univest presents this as a company overview rooted in the supplied data, not in conjecture.
Track Sudeep Pharma Share Price on Univest
Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Sudeep Pharma Share Price on Univest for live share price updates, key financial ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Sudeep Pharma Share Price Today alongside valuation metrics, company news and sector comparison in one place.
For investors monitoring Sudeep Pharma Share Price Live, Univest keeps the focus on verified numbers such as market cap, P/E, P/B, ROE, ROCE, EPS and book value. That structure makes it easier to follow Sudeep Pharma Latest News and related Stock Updates without relying on unsupported market talk.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Sudeep Pharma Share Price rising today?
Ans. The supplied data confirms a 5.00% rise to Rs 1,161.50, but it does not establish a company-specific catalyst. The session also showed Rs 1.61 crore turnover and a close at the day high.
What is Sudeep Pharma Share Price today?
Ans. Sudeep Pharma Share Price today is Rs 1,161.50, up Rs 55.30 from the previous close of Rs 1,106.20. The stock opened at Rs 1,109.80 and finished the session at its day high.
What is the market capitalisation of Sudeep Pharma?
Ans. Sudeep Pharma’s market capitalisation is Rs 12,515.84 crore. That figure is above the same-industry median market cap of Rs 741.38 crore, while remaining below the benchmark average of Rs 13,917.82 crore.
How does Sudeep Pharma compare on valuation?
Ans. Sudeep Pharma has a P/E ratio of 68.41 and P/B ratio of 13.52. Both are above the same-industry median and average, indicating a richer valuation than many benchmark peers in pharmaceuticals.
What do ROE and ROCE show for Sudeep Pharma?
Ans. ROE is 25.37% and ROCE is 28.50%. Both are higher than the same-industry benchmark median and average, which points to stronger reported profitability and capital efficiency on the supplied numbers.
How does Sudeep Pharma compare with listed pharma peers?
Ans. Compared with peers such as Sun Pharmaceutical, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla, Sudeep Pharma shows stronger ROCE and a higher valuation than several names in the group.
